Together, these findings opened the door to exploring the therapeutic potential of the SETX–ZPR1 axis in regulating pathogenic R-loops in neurodegenerative diseases subject to abnormal levels of R-loops such as SMA and ALS4. This evidence concerns the gene SETX and neurodegenerative disease.